Analytical Platforms in Metabolomics
In metabolomics, genuine undertakings are placed assets into the headway of reasonable logical strategies. Metabolomics, the most youthful field in the 'omics family, is developing quickly. Growing straightforwardly behind genomics, transcriptomics, and proteomics, metabolomics is the broad examination of little molecule metabolites. Ensuing to most metabolites are delivered by enzymatic proteins that result from quality articulation, and metabolites give animals their biochemical properties, the metabolome joins genotype with phenotype. Metabolomics is up 'til now developing, notwithstanding, as traders alter division and revelation instruments to meet its challenges and the examination bunch decodes and consolidates the amazing data they are picking up. The late speedy headway of an extent of investigative stages, including GC, HPLC, UPLC, CE coupled to MS and NMR spectroscopy, could enable segment, recognizable proof, depiction and assessment of such metabolites and related metabolic pathways. Continued with change of these demonstrative stages will enliven sweeping use and coordination of metabolomics into structures science. NIH Awards $1.6M to Fund microRNA Biomarker Research in Cancer, Alzheimer's Disease . The Bill and Melinda Gates Foundation today pronounced $7.7 million in financing for 10 new concedes to recognize biomarkers for diagnosing tuberculosis (TB) in low-asset settings.
- Metabolite extraction
- Nuclear magnetic resonance (NMR)
- Mass spectrometry
- Gas chromatography–mass spectrometry (GC–MS)
- Liquid chromatography–mass spectrometry (LC–MS)
- Capillary electrophoresis–mass spectrometry (CE–MS)
- Ratio analysis of NMR/MS
Related Conference of Analytical Platforms in Metabolomics
Analytical Platforms in Metabolomics Conference Speakers
Recommended Sessions
- Analytical Platforms in Metabolomics
- Case Reports
- Clinical Metabolomics & Lipidomics
- Frontiers of Metabolomics Research
- Human Metabolomics
- Mass Spectrometry based Metabolomics
- Metabolic Modelling
- Metabolic Syndrome
- Metabolomic Analysis
- Metabolomic Devices
- Metabolomic profiling
- Metabolomics and Cancer Research
- Metabolomics in Precision Medicine
- Plant & Environmental Metabolomics
- Protein Expression and Analysis
- Proteomics and its Medicinal Research
- Proteomics for Bioinformatics
- Proteomics from Discovery to Function
- Single Cell Metabolomics
- Urine Metabolomics
Related Journals
Are you interested in
- 3D Structure Determination - Structural Biology-2026 (France)
- Advanced Drug Delivery Systems for Metabolic Therapy - DRUG CHEMISTRY CONF 2026 (France)
- Advanced Techniques in Structural Biology - Structural Biology-2026 (France)
- AI & Computational Structural Biology - Structural Biology-2026 (France)
- Biochemistry and Biophysics - Structural Biology-2026 (France)
- Biomarker-Guided Drug Development - DRUG CHEMISTRY CONF 2026 (France)
- Chemical Biology Tools in Metabolic Research - DRUG CHEMISTRY CONF 2026 (France)
- Computational Approach in Structural Biology - Structural Biology-2026 (France)
- Computational Drug Design and Molecular Modeling - DRUG CHEMISTRY CONF 2026 (France)
- Drug Designing and Biomarkers - Structural Biology-2026 (France)
- Drug Resistance and Therapeutic Durability - DRUG CHEMISTRY CONF 2026 (France)
- Enzyme Modulation Approaches in Antidiabetic Drug Design - DRUG CHEMISTRY CONF 2026 (France)
- Epigenetic Regulation and Small-Molecule Therapeutics - DRUG CHEMISTRY CONF 2026 (France)
- Future Directions in Drug Chemistry for Diabetes Management - DRUG CHEMISTRY CONF 2026 (France)
- Hybrid Approaches for Structure Prediction - Structural Biology-2026 (France)
- Lipid Chemistry and Metabolic Regulation - DRUG CHEMISTRY CONF 2026 (France)
- Medicinal Chemistry Strategies for Metabolic Disorders - DRUG CHEMISTRY CONF 2026 (France)
- Membrane Proteins and Receptors - Structural Biology-2026 (France)
- Molecular Modelling and Dynamics - Structural Biology-2026 (France)
- Natural Product Chemistry in Diabetes Drug Discovery - DRUG CHEMISTRY CONF 2026 (France)
- Oxidative Stress Modulation through Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- Peptide and Protein-Based Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- Pharmacokinetics and Drug Metabolism Studies - DRUG CHEMISTRY CONF 2026 (France)
- Prodrug Design and Chemical Activation Strategies - DRUG CHEMISTRY CONF 2026 (France)
- Proteomics and Genomics - Structural Biology-2026 (France)
- Regulatory Chemistry and Drug Safety Assessment - DRUG CHEMISTRY CONF 2026 (France)
- Structural Bioinformatics and Computational Biology - Structural Biology-2026 (France)
- Structural Biology in Cancer Research - Structural Biology-2026 (France)
- Structural Virology - Structural Biology-2026 (France)
- Structural Virology and Infectious Diseases - Structural Biology-2026 (France)
- Structure-Based Drug Discovery - Structural Biology-2026 (France)
- Structure-Based Solutions to Global Health Challenges - Structural Biology-2026 (France)
- Structure-Function Relationships - Structural Biology-2026 (France)
- Structure–Activity Relationship Studies in Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- Synthetic Chemistry Innovations in Drug Development - DRUG CHEMISTRY CONF 2026 (France)
- Targeting Pancreatic Function through Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- The Structural Basis of Disease - Structural Biology-2026 (France)
- Translational Drug Chemistry from Bench to Clinic - DRUG CHEMISTRY CONF 2026 (France)
